Description

n-(3-Cyano-4,5,6,7-Tetrahydro-1-Benzothien-2-Yl)-1-(4-Ethoxyphenyl)-4-Oxo-1,4-Dihydro-3-Pyridazinecarboxamide is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the research and development of novel therapeutic agents, particularly in kinase inhibitor programs. It is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of targeted drug candidates.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel small-molecule drug candidates, particularly for oncology and inflammatory disease targets.
• Kinase Inhibitor Research: Serves as a core scaffold or a functionalized fragment in the design and development of potent and selective kinase inhibitors.
• Medicinal Chemistry: Used in structure-activity relationship (SAR) studies to optimize the potency, selectivity, and pharmacokinetic properties of lead compounds.
• Chemical Biology: Employed as a tool compound or a labeled probe for studying specific biological pathways and target engagement.
• Process Chemistry Development: Utilized in the scale-up and optimization of synthetic routes for active pharmaceutical ingredients (APIs) under GMP conditions.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations providing custom synthesis and process development services for the pharmaceutical industry.

Basic Information

Product Name	n-(3-Cyano-4,5,6,7-Tetrahydro-1-Benzothien-2-Yl)-1-(4-Ethoxyphenyl)-4-Oxo-1,4-Dihydro-3-Pyridazinecarboxamide
CAS No.	879580-10-6
Molecular Formula	C23H20N4O3S
Molecular Weight	432.50 g/mol
Synonyms	N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-1-(4-ethoxyphenyl)-4-oxo-1,4-dihydropyridazine-3-carboxamide; 1-(4-Ethoxyphenyl)-N-(4,5,6,7-tetrahydro-3-cyano-1-benzothien-2-yl)-4-oxo-1,4-dihydro-3-pyridazinecarboxamide; 879580-10-6; Pyridazinecarboxamide derivative; Benzothiophene-pyridazine hybrid
EINECS	Contact for details

Quality Control

Our n-(3-Cyano-4,5,6,7-Tetrahydro-1-Benzothien-2-Yl)-1-(4-Ethoxyphenyl)-4-Oxo-1,4-Dihydro-3-Pyridazinecarboxamide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, MS). Certificates of Analysis (COA) detailing batch-specific results are provided to ensure traceability and compliance with your research or manufacturing requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound may be hygroscopic; keep the container tightly sealed in a dry environment to prevent moisture uptake.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.